Agomab Therapeutics NV (AGMB) Receivables (2024 - 2025)
Agomab Therapeutics (AGMB) posted Receivables of $7.1 million for Q4 2025, up 113.1% on a QoQ basis from $3.3 million in Q4 2024, and up 113.1% year-over-year from $3.3 million in Q4 2024.
Powered by 
Analysis
Agomab Therapeutics NV (AGMB) Receivables (2024 - 2025) Analysis & Trends
Agomab Therapeutics has reported Receivables for 2 years, with the latest figure at $7.1 million in Q4 2025.
- On a quarterly basis, Receivables rose 113.1% year-over-year to $7.1 million in Q4 2025; TTM through Dec 2025 was $7.1 million, a 113.1% increase from a year earlier, with the FY2025 full-year figure at $7.1 million, up 110.4% from the prior year.
- Receivables was $7.1 million for Q4 2025 at Agomab Therapeutics, up from $3.3 million in the prior quarter.
- The five-year high for Receivables was $7.1 million in Q4 2025, with the low at $3.3 million in Q4 2024.
Peer Set
Peer Comparison
API Access
Agomab Therapeutics NV Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();